ESE survey for aggressive pituitary tumours and pituitary carcinomas |
Welcome to the Survey
Thank you for participating in this survey, your feedback is very important to us.
Please find below the overall topics that will be covered within this survey, and the type of data that will be requested:
Part 1: Physician details & Patient Overview
Part 2: Aggressive Pituitary Tumours/carcinomas - Initial Diagnosis
Part 3: Aggressive Pituitary Tumours & Carcinomas - Surgery for the Pituitary Tumour & Histopathology
Part 4: Aggressive Pituitary Tumours & Carcinomas - Radiotherapy for the pituitary tumour
Part 5: Additional questions on corticotroph tumours
Part 6a: Treatment with Temozolomide
Part 6b: Second treatment period with temozolomide
Part 7: Treatment - Immune Checkpoint Inhibitors
Part 8: Treatment - other chemotherapies
Part 9: Treatment with Peptide Receptor Radiotargeted Therapy
Part 10: Additional questions on Pituitary Carcinomas; Diagnosis and surgery of metastases, and Histopathology
Part 11: Pituitary Carcinomas - Radiotherapy for metastases
Part 12: Pituitary Carcinomas - Liver embolization
Part 13: Final comments and the end of the Survey